4:35 PM
 | 
Apr 05, 2018
 |  BC Extra  |  Company News

Management Tracks: CRISPR, Moderna

Gene editing company CRISPR Therapeutics AG (NASDAQ:CRSP) hired Steve Caffé as head of regulatory affairs. Caffé was SVP at Ra Pharmaceuticals Inc. (NASDAQ:RARX).

mRNA company Moderna Therapeutics Inc. (Cambridge, Mass.) hired Megan Pace as chief corporate affairs officer. She was SVP of strategic operations and communications at Agios Pharmaceuticals Inc. (NASDAQ:AGIO).

Mallinckrodt plc (NYSE:MNK) said Chairman Melvin Booth will retire in May 2018. Angus Russell, a board member, will succeed as chairman.

Blood cancer...

Read the full 349 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >